Effect of Dietary Supplementation with Evening Primrose Oil on Vascular Thrombogenesis in Hyperlipemic Rabbits

Summary

The dietary intake of saturated fatty acids affects arteriosclerosis. We studied the effect of supplementation (15% wt/wt) of a hyperlipemic diet (1.3% cholesterol) with evening primrose oil (Oenothera biennis) in four groups of 10 rabbits each. After 6 weeks the aortic endothelium was analyzed morphologically with scanning electron microscopy, and the arterial wall was studied with morphometric techniques and cell nucleus counts. Endothelial functioning was analyzed by measuring prostacyclin synthesis, and thrombogenicity of the subendothelium was studied by perfusion in a Baumgartner annular chamber. Evening primrose oil reduced hypercholesterolemia (from 29 ± 3 to 12 ± 2 nmol/l), increased HDL-cholesterol (from 0.5 ± 0.06 to 0.8 ± 0.09 nmol/l) and doubled prostacyclin synthesis (from 2.7 ± 2 to 6.2 ± 0.7 ng/mg aorta) in rabbits on the hyperlipemic diet, reduced subendothelial surface occupied by platelets (from 6.9 ± 0.4 to 4.8 ± 0.3%), and reduced human platelet adhesion on the subendothelium (from 53.3 ± 6% to 38 ± 8%, respect to total occupation). Morphological analyses showed that evening primrose oil diminished endothelial lesions caused by the atherogenic diet, reducing area of the arterial wall (from 6.9 ± 0.2 to 4.7 ± 0.2 μm² × 10⁶) and the degree of neointimal proliferation (from 0.6 ± 0.02 to 0.4 ± 0.09 μm² × 10⁶). We conclude that in our experimental model, this dietary supplement enhanced the antithrombotic capacity of the endothelium, reduced subendothelial thrombogenicity, and diminished the extent of vascular wall lesions caused by the hyperlipemic diet.

• References

• 1 Sinclair HM. Deficiency of essential fatty acids and atherosclerosis. Lancet 1956; 1: 381-3.
• 2 Sinclair HM. History of essential fatty acids. In: Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine. DF Horrobin (Ed). New York: Wiley-Liss; 1990: 1-20.
• 3 Keys A. Seven Countries. A Multivariate Analysis of Death and Coronary Heart Disease Cambridge: Harvard University Press; 1980
• 4 Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. III. Differences among individuals. Metabolism 1965; 14: 766-75.
• 5 Siess W, Roth P, Scherer B, Kurzmann Y, Bohlig B, Weber PC. Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet 1980; 1: 441-4.
• 6 Yung-Sheng Huang, Bassam A. Nassar. Modulation of tissue fatty acid composition, prostaglandin production, and cholesterol levels by dietary manipulation of n-3 and n-6 essential fatty acid metabolites. In: Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine. DF Horrobin (Ed). New York: Wiley-Liss; 1990: 127-44.
• 7 Horrobin DF, Manku MS. Clinical Biochemistry of essential fatty acids. In: Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine. DF Horrobin (Ed). New York: Wiley-Liss; 1990: 21-54.
• 8 Horrobin DF. Omega-6 and omega-3 essential fatty acids in atherosclerosis. Seminars in Thrombosis and Hemostasis 1993; 19: 129-37.
• 9 Cameron NE, Cotter MA, Dines KC, Robertson S, Cox D. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen. Br J Pharmacol 1993; 109: 972-7.
• 10 Gamma-Linolenic Acid Multicentre Trial Group.. The effect of gamma-linolenic acid on diabetic neuropathy: a multicentre trial. In: Treatment of Diabetic Neuropathy: a New Approach. DF Horrobin (Ed). Edinburgh; Churchill Livingstone: 1992: 119-130.
• 11 Jamal GA. Prevention and treatment of diabetic distal polyneuropathy by the supplementation of gamma-linolenic acid. In: Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine. DF Horrobin (Ed). New York: Wiley-Liss; 1990: 487-504.
• 12 Brenner RR. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 1981; 20: 41-7.
• 13 Huang YS, Manku MS, Horrobin DF. The effects of dietary cholesterol on blood and liver polyunsaturated fatty acids and on plasma cholesterol in rats fed various types of fatty acids diet. Lipids 1984; 19: 664-73.
• 14 Sugano M, Ide T, Ishida T, Yoshida K. Hypocholesterolemic effect of gamma-linolenic acid as evening primrose oil. Ann Nutr Metab 1986; 30: 289-99.
• 15 Hornstra G, Lussenburg RN. Relationship between the type of dietary fatty acid and arterial thrombosis tendency in rats. Atherosclerosis 1975; 22: 499-516.
• 16 Renaud S, McGregor L, Morazain R, Thevenon C, Benoit C, Dumont E, Mendy F. Comparative beneficial effects on platelet functions and atherosclerosis of dietary lonoleic acids in the rabbit. Atherosclerosis 1982; 45: 43-51.
• 17 Belch JJ, Shaw B, O´Dowd A, Saniabadi A, Leiberman P, Sturrock RD, Forbes CD. Evening primrose oil (Efamol) in the treatment of Raynaud’s phenomenon: a double blid study. Thromb Haemost 1985; 54: 490-4.
• 18 Boberg M, Vessby B, Selinus I. Effects of dietary supplementation with n-6 and n-3 long-chaiu polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients. Acta Med Scand 1986; 220: 153-60.
• 19 Takahashi R, Morse N, Horrobin DF. Plasma, platelet and aorta fatty acids composition in response to dietary n-6 and n-3 fats supplementation in a rat model of non-insulin-dependent diabetes. J Nutr Sci Vitaminol (Tokyo) 1988; 34: 413-21.
• 20 McGregor L, Smith AD, Sidey M, Belin J, Zilhka KJ, McGregor JL. Effects of dietary linoleic acid and gamma linolenic acid on platelets of patgients with multiple sclerosis. Acta Neurol Scand 1989; 80: 23-7.
• 21 Guivernau M, Meza N, Barja P, Roman O. Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 311-16.
• 22 Baumgartner HR. Platelet interaction with vascular structures. Thromb Diath Haemorrh Suppl 1972; 51: 161-71.
• 23 Horrobin DF, Huang YS. The role of linoleic acid and its metabolites in the lowering of plasma cholesterol and the prevention of cardiovascular disease. Int J Cardiol 1987; 17: 241-55.
• 24 Rivers JPW, Frankel TL. Essential fatty acid deficiency. Br Med Bull 1981; 37: 59-64.
• 25 Bilsel S, San T, Ersahin C, Moini H, Okar Y, Emerk K. Morphological changes in carotid arteries of rabbits induced by defibrotide infusion. Thromb Res 1994; 76: 433-40.
• 26 Davies MJ, Woolf N, Rowless PM, Pepper J. Morphology of the endotelium over atherosclerotic plaques in human coronary arteries. Br Heart J 1988; 60: 459-64.
• 27 Zhao B, Zhang Y, Liu B, Nawroth P, Dierichs R. Endothelial cells injured by oxidized low density lipoprotein. Am J Hematol 1995; 49: 250-2.
• 28 Goodnight SH, Inkeles SB, Kocach NL, Connor WE. Reduced prostacyclin survival after fasting-induced elevation of plasma free fatty acids. Thromb Haemostas 1985; 54: 418-21.
• 29 Tremoli E, Maderna P, Sirtori M, Sirtori C. Platelet aggregation and malonilaldehyde formation in type IIA hypercholesterolemic patients. Haemostasis 1979; 8: 47-53.
• 30 Warso M, Lands W. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull 1983; 39: 277-80.
• 31 De la Cruz JP, Villalobos MA, Martin M, Carmona JA, Smith JM, Sanchez de la Cuesta F. Effects of dietary n-6 polyunsaturated fatty acids in platelet-vascular wall interaction in rabbits with hypercholesterolemic diet. Abstract Book. 66th Congress of the European Atherosclerosis Society 1996: P168.
• 32 Badimon JJ, Badimon L, Turitto VT, Fuster V. Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. Arteriosclerosis and Thrombosis 1992; 11: 395-402.
• 33 De La Cruz JP, Martin-Romero M, Carmona JA, Villalobos MA, Sanchez de la Cuesta F. Effect of evening primrose oil on platelet aggregation in rabbits fed an atherogenic diet. Thromb Res 1997; 87: 141-9.